HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A case of fibrin sealant application for closing benign trachea-esophageal fistula (TEF).

Abstract
Surgical treatment of upper airway-esophageal communications are frequently lead to failure. Having previous experience of thoracic administration of Tissucol fibrin glue authors attempted the local application in a case of TEF. A young lady suffering from myasthenia gravis required longstanding artificial ventilation. Not surprisingly a TEP developed in the area of the tracheostomy. There was no room for surgical repair of the TEF. Two administrations of rapid acting form of Tissucol was needed following local astringent therapy and enzymatic debridement to achieve a complete and permanent closure of a tracheobronchial sinus in a diameter of 5 mm. In addition of meticulous technique and of general supporting therapy special attention was paid to the followings: 1/healthy wound edges 2/ local infection control 3/dry environment 4/patient building up strategy.
AuthorsI Benkó, T F Molnár, O P Horváth
JournalActa chirurgica Hungarica (Acta Chir Hung) Vol. 36 Issue 1-4 Pg. 25-6 ( 1997) ISSN: 0231-4614 [Print] Hungary
PMID9408274 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Infective Agents, Local
  • Astringents
  • Fibrin Tissue Adhesive
  • Tissue Adhesives
  • Water
Topics
  • Adult
  • Anti-Infective Agents, Local (therapeutic use)
  • Astringents (therapeutic use)
  • Enzyme Therapy
  • Female
  • Fibrin Tissue Adhesive (therapeutic use)
  • Follow-Up Studies
  • Humans
  • Myasthenia Gravis (therapy)
  • Respiration, Artificial (adverse effects)
  • Tissue Adhesives (therapeutic use)
  • Tracheoesophageal Fistula (etiology, therapy)
  • Tracheostomy (adverse effects)
  • Water
  • Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: